1. Home
  2. XENE vs INSP Comparison

XENE vs INSP Comparison

Compare XENE & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$42.43

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$98.00

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XENE
INSP
Founded
1996
2007
Country
Canada
United States
Employees
N/A
1246
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.8B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
XENE
INSP
Price
$42.43
$98.00
Analyst Decision
Strong Buy
Buy
Analyst Count
11
17
Target Price
$53.91
$137.63
AVG Volume (30 Days)
857.1K
1.8M
Earning Date
02-26-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.77
EPS
N/A
1.48
Revenue
$7,500,000.00
$882,622,000.00
Revenue This Year
N/A
$15.00
Revenue Next Year
N/A
$11.24
P/E Ratio
N/A
$65.85
Revenue Growth
N/A
16.81
52 Week Low
$26.74
$70.77
52 Week High
$46.60
$216.01

Technical Indicators

Market Signals
Indicator
XENE
INSP
Relative Strength Index (RSI) 44.90 45.06
Support Level $40.41 $90.49
Resistance Level $46.36 $97.00
Average True Range (ATR) 1.59 4.42
MACD -0.43 -1.42
Stochastic Oscillator 30.35 29.92

Price Performance

Historical Comparison
XENE
INSP

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Share on Social Networks: